Sahajanand Medical Technologies Ltd announced an intimation regarding changes to its credit ratings, as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, including an upgradation of credit rating from an unspecified agency, with details not provided, and an upgrade of its Bank Loan Facilities by CRISIL Ratings Limited, which also includes its Wholly Owned Material Subsidiary SMT Cardiovascular Private Limited. The rating agencies have not specified the amounts or ratings associated with either the upgradation or the upgrade of the Bank Loan Facilities, and no withdrawals or assignments were noted.